Skip to main content
. 2022 Jan 30;2022:1565207. doi: 10.1155/2022/1565207

Table 2.

Impact of tumor localization on the OS by univariate and multivariate survival analysis before PSM.

Characteristics Univariate analysis Multivariate analysis
Log rank χ2 P value HR 95% CI P value
Tumor localization 49.4 <0.001
DGC Reference
OGC 1.29 1.23-1.36 <0.001
PGC 1.15 1.09-1.22 <0.001

Age 76.2 <0.001
18-49 Reference
50-59 1.01 0.84-1.22 0.886
60-69 1.04 0.87-1.26 0.644
70-79 1.72 1.41-2.11 <0.001
≥80 1.71 1.35-2.17 <0.001

Race 12.3 0.007
White Reference
Black 1.07 0.89-1.28 0.467
API 0.89 0.75-1.06 0.192
AI 1.12 0.57-2.20 0.733

Marital status 28.3 <0.001
Divorced Reference
Married 0.98 0.81-1.19 0.858
Widowed 1.04 0.81-1.34 0.758
Single 1.08 0.86-1.35 0.508

Median household income 16.7 <0.001
Quartile 1 Reference
Quartile 2 0.91 0.81-1.02 0.102
Quartile 3 1.06 0.94-1.19 0.319
Quartile 4 0.89 0.79-1.00 0.047

TNM stage 437.0 <0.001
I Reference
II 1.84 1.45-2.34 <0.001
III 3.54 2.84-4.41 <0.001
IV 4.22 3.34-5.32 <0.001

Tumor size 244.6 <0.001
≤2 Reference
≤5 1.47 1.14-1.88 0.002
>5 cm 2.05 1.59-2.64 <0.001
Unknown 2.01 1.57-2.58 <0.001

Regional node examined 122.1 <0.001
≤16 Reference
>16 0.83 0.70-0.99 0.041

Bone metastasis 81.6 <0.001
Yes Reference
No 0.86 0.65-1.14 0.290

Liver metastasis 87.0 <0.001
Yes Reference
No 0.88 0.68-1.13 0.309

Lung metastasis 74.3 <0.001
Yes Reference
No 0.86 0.63-1.17 0.331
Surgery 527.7 <0.001
No Reference
Yes 0.35 0.29-0.42 <0.001

Radiation 22.6 <0.001
No/unknown Reference
Yes 0.98 0.84-1.14 0.801

Chemotherapy 11.0 <0.001
No/unknown Reference
Yes 0.43 0.37-0.50 <0.001

OS: overall survival; PSM: propensity score matching; HR: hazard ratio; CI: confidence interval.